CSPC Pharmaceutical Group Ltd. Stock Other OTC
Stocks
CHJTF
HK1093012172
Pharmaceuticals
OTC Markets Traded| Market Cap | 96.04B 12.25B 10.73B 9.95B 9.15B 17.26B 1,179B 17.47B 119B 46.45B 578B 45.97B 44.98B 1,996B | P/E 2026 * |
11.6x | P/E 2027 * | 13.6x |
|---|---|---|---|---|---|
| Enterprise Value | 85.17B 10.86B 9.52B 8.82B 8.12B 15.31B 1,046B 15.5B 105B 41.2B 513B 40.77B 39.89B 1,770B | EV / Sales 2026 * |
2.39x | EV / Sales 2027 * | 2.35x |
| Free-Float |
67.42% | Yield 2026 * |
4.33% | Yield 2027 * | 4.38% |
| 1 day | +3.00% |
| Manager | Title | Age | Since |
|---|---|---|---|
Lei Cai
CEO | Chief Executive Officer | 46 | 2025-12-18 |
Qing Jie Wei
COO | Chief Operating Officer | 56 | 2025-12-18 |
Weiping Chen
PRN | Corporate Officer/Principal | 47 | 2004-06-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Dong Chen Cai
CHM | Chairman | 72 | 2011-08-25 |
Bo Wang
BRD | Director/Board Member | 66 | 2012-12-20 |
Qing Jie Wei
BRD | Director/Board Member | 56 | 2025-12-18 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.00% | -.--% | - | - | 12.26B | |
| -0.69% | +0.89% | +50.28% | +154.04% | 1,048B | |
| +2.25% | +3.40% | +52.09% | +49.29% | 603B | |
| +0.07% | +5.10% | +37.12% | +79.19% | 452B | |
| -0.42% | +0.67% | +30.81% | +21.54% | 327B | |
| -0.16% | +2.74% | +36.02% | +38.04% | 283B | |
| +1.68% | +1.08% | +22.70% | +17.83% | 259B | |
| -1.40% | -3.34% | -24.63% | -41.91% | 219B | |
| +0.57% | +2.66% | +20.33% | +56.25% | 198B | |
| +0.94% | -0.18% | +19.33% | +69.28% | 162B | |
| Average | +0.57% | +1.74% | +27.12% | +49.28% | 394.63B | |
| Weighted average by Cap. | +0.22% | +1.69% | +36.28% | +73.94% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 35.68B 4.55B 3.99B 3.69B 3.4B 6.41B 438B 6.49B 44.1B 17.26B 215B 17.08B 16.71B 741B | 35.2B 4.49B 3.93B 3.64B 3.35B 6.33B 432B 6.4B 43.5B 17.02B 212B 16.85B 16.48B 731B |
| Net income | 7.94B 1.01B 887M 822M 757M 1.43B 97.48B 1.44B 9.81B 3.84B 47.77B 3.8B 3.72B 165B | 6.92B 882M 773M 716M 659M 1.24B 84.95B 1.26B 8.55B 3.35B 41.63B 3.31B 3.24B 144B |
| Net Debt | -10.86B -1.39B -1.21B -1.12B -1.04B -1.95B -133B -1.98B -13.43B -5.25B -65.38B -5.2B -5.09B -226B | -13.44B -1.71B -1.5B -1.39B -1.28B -2.42B -165B -2.44B -16.61B -6.5B -80.89B -6.43B -6.29B -279B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
